FRONTIERS IN ONCOLOGY Journal

publication venue for

Systemic benefit of radiation therapy via abscopal effect. 12. 2022
Thyroid Cancer Screening Using Tumor-Associated DN T Cells as Immunogenomic Markers. 12. 2022
Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis. 11. 2022
The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma. 11. 2021
Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma. 11. 2021
Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma. 10. 2020
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness. 9. 2019
The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells. 9. 2019
Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance 2023
Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes 2020
Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance 2019
Gene Therapy Leaves a Vicious Cycle 2019
New Frontiers for the Cytoskeletal Protein LASP1 2018

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

2234-943X

journal abbreviation

FRONT ONCOL